Abstract
After initiating disease-modifying therapy (DMT) in multiple sclerosis (MS), assessment of treatment response is critical. Early disease activity
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
